Generally, healthy people can produce all the ALA the body needs
Wharton S, Davies M, Dicker D, Lingvay I, Mosenzon O, Rubino DM, et al
External resources Efficacy and safety of retatrutide: systematic review and meta-analysis (PMC) Triple hormone receptor agonist retatrutide for obesity: Phase 2 trial (NEJM) Tesamorelin clinical pharmacology and safety (NCBI LiverTox) Safety and metabolic effects of tesamorelin in type 2 diabetes (PMC) Tesamorelin prescribing information and side effects (Mayo Clinic) Retatrutide for metabolic dysfunction-associated steatotic liver disease (Nature Medicine) For researchers serious about optimizing their peptide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
Subjective improvement in pain, function, and activity tolerance provides the primary effectiveness signal
doi: 10.1016/j.ejphar.2010.10.008 91 IwaiT.SawabeT.TanimitsuK.SuzukiM.Sasaki-HamadaS.OkaJ